Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | Dow Jones US Select Medical Equipment Capped 35/20 |
| Investment focus | Equity, United States, Health Care |
| Fund size | GBP 175 m |
| Total expense ratio | 0.25% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Investment approach | Long-only |
| Sustainability | No |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in GBP) | 19.94% |
| Inception/ Listing Date | 3 August 2020 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | iShares |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | State Street Fund Services (Ireland) Limited |
| Investment Advisor | |
| Custodian Bank | State Street Custodial Services (Ireland) Limited |
| Revision Company | Deloitte |
| Fiscal Year End | 30 November |
| Swiss representative | BlackRock Asset Management Schweiz AG |
| Swiss paying agent | State Street Bank International GmbH, Munich, Zurich Branch |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Italy | 26.0% |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | Bank of New York Mellon|Euroclear|JP Morgan|State Street Bank |
| Securities lending | No |
| Securities lending counterparty |
| Abbott Laboratories | 18.67% |
| Intuitive Surgical | 12.97% |
| Medtronic Plc | 11.31% |
| Stryker | 10.85% |
| Boston Scientific Corp. | 6.97% |
| Edwards Lifesciences Corp. | 5.08% |
| Becton Dickinson | 5.04% |
| IDEXX Laboratories | 4.26% |
| DexCom | 3.41% |
| ResMed, Inc. | 3.38% |
| United States | 85.76% |
| Ireland | 13.59% |
| Other | 0.65% |
| Healthcare | 99.88% |
| Non-Corporate | 0.07% |
| Finance | 0.00% |
| Other | 0.05% |
| YTD | -16.63% |
| 1 month | +2.97% |
| 3 months | +2.21% |
| 6 months | -3.70% |
| 1 year | -14.75% |
| 3 years | +0.00% |
| 5 years | -11.68% |
| Since inception (MAX) | +9.19% |
| 2025 | -0.60% |
| 2024 | +12.30% |
| 2023 | -1.11% |
| 2022 | -9.96% |
| Volatility 1 year | 19.94% |
| Volatility 3 years | 18.36% |
| Volatility 5 years | 19.72% |
| Return per risk 1 year | -0.74 |
| Return per risk 3 years | 0.00 |
| Return per risk 5 years | -0.12 |
| Maximum drawdown 1 year | -29.83% |
| Maximum drawdown 3 years | -33.45% |
| Maximum drawdown 5 years | -33.45% |
| Maximum drawdown since inception | -33.45% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| Euronext Paris | EUR | UMDV | - - | - - | - |
| gettex | EUR | U5MD | - - | - - | - |
| Bolsa Mexicana de Valores | MXN | - | UMDVN MM | UMDVN.MX | |
| Euronext Amsterdam | USD | UMDV | UMDV NA INAVUMD5 | UMDV.AS 4J86INAV.DE | |
| SIX Swiss Exchange | USD | UMDV | UMDV SE INAVUMD5 | UMDV.S 4J86INAV.DE | |
| XETRA | EUR | U5MD |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares S&P 500 Health Care Sector UCITS ETF (Acc) | 2,827 | 0.15% p.a. | Accumulating | Full replication |
| iShares Nasdaq US Biotechnology UCITS ETF | 1,033 | 0.35% p.a. | Accumulating | Sampling |
| Xtrackers MSCI USA Health Care UCITS ETF 1D | 854 | 0.12% p.a. | Distributing | Full replication |
| State Street SPDR S&P U.S. Health Care Select Sector UCITS ETF USD | 530 | 0.15% p.a. | Accumulating | Full replication |
| Invesco US Health Care Sector UCITS ETF | 489 | 0.14% p.a. | Accumulating | Swap-based |